H. Abali Et Al. , "Granisetron plus alprazolam versus granisetron alone in the control of emesis in patients with operable breast cancer receiving anthracycline containing chemotherapy: A phase III trial.," 40th Annual Meeting of the American-Society-of-Clinical-Oncology , vol.22, Louisiana, United States Of America, 2004
Abali, H. Et Al. 2004. Granisetron plus alprazolam versus granisetron alone in the control of emesis in patients with operable breast cancer receiving anthracycline containing chemotherapy: A phase III trial.. 40th Annual Meeting of the American-Society-of-Clinical-Oncology , (Louisiana, United States Of America).
Abali, H., Oyan, B., Ozisik, Y., & Guler, N., (2004). Granisetron plus alprazolam versus granisetron alone in the control of emesis in patients with operable breast cancer receiving anthracycline containing chemotherapy: A phase III trial. . 40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, United States Of America
Abali, H Et Al. "Granisetron plus alprazolam versus granisetron alone in the control of emesis in patients with operable breast cancer receiving anthracycline containing chemotherapy: A phase III trial.," 40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, United States Of America, 2004
Abali, H Et Al. "Granisetron plus alprazolam versus granisetron alone in the control of emesis in patients with operable breast cancer receiving anthracycline containing chemotherapy: A phase III trial.." 40th Annual Meeting of the American-Society-of-Clinical-Oncology , Louisiana, United States Of America, 2004
Abali, H. Et Al. (2004) . "Granisetron plus alprazolam versus granisetron alone in the control of emesis in patients with operable breast cancer receiving anthracycline containing chemotherapy: A phase III trial.." 40th Annual Meeting of the American-Society-of-Clinical-Oncology , Louisiana, United States Of America.
@conferencepaper{conferencepaper, author={H Abali Et Al. }, title={Granisetron plus alprazolam versus granisetron alone in the control of emesis in patients with operable breast cancer receiving anthracycline containing chemotherapy: A phase III trial.}, congress name={40th Annual Meeting of the American-Society-of-Clinical-Oncology}, city={Louisiana}, country={United States Of America}, year={2004}}